Page 79 - Read Online

Boyajian et al. Microbiome Res Rep 2024;3:29 https://dx.doi.org/10.20517/mrr.2024.05 Page 31 of 35

PMC
122. Kheniser K, Saxon DR, Kashyap SR. Long-term weight loss strategies for obesity. J Clin Endocrinol Metab 2021;106:1854-66. DOI
PubMed PMC
123. Machado AM, Guimarães NS, Bocardi VB, et al. Understanding weight regain after a nutritional weight loss intervention: systematic
review and meta-analysis. Clin Nutr ESPEN 2022;49:138-53. DOI
124. Jackson VM, Breen DM, Fortin JP, et al. Latest approaches for the treatment of obesity. Expert Opin Drug Discov 2015;10:825-39.
DOI
125. van Baak MA, Mariman ECM. Mechanisms of weight regain after weight loss - the role of adipose tissue. Nat Rev
Endocrinol 2019;15:274-87. DOI PubMed
126. Perry AS, Tanriverdi K, Risitano A, et al. The inflammatory proteome, obesity, and medical weight loss and regain in humans.
Obesity 2023;31:150-8. DOI PubMed PMC
127. Fitzgerald KN, Hodges R, Hanes D, et al. Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot
randomized clinical trial. Aging 2021;13:9419-32. DOI PubMed PMC
128. Waziry R, Ryan CP, Corcoran DL, et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in
healthy adults from the CALERIE trial. Nat Aging 2023;3:248-57. DOI PubMed PMC
129. Lilja S, Stoll C, Krammer U, et al. Five days periodic fasting elevates levels of longevity related christensenella and sirtuin expression
in humans. Int J Mol Sci 2021;22:2331. DOI PubMed PMC
130. McGrattan AM, McGuinness B, McKinley MC, et al. Diet and inflammation in cognitive ageing and Alzheimer’s disease. Curr Nutr
Rep 2019;8:53-65. DOI PubMed PMC
131. Filippou CD, Tsioufis CP, Thomopoulos CG, et al. Dietary approaches to stop hypertension (DASH) diet and blood pressure
reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr
2020;11:1150-60. DOI PubMed PMC
132. Elsayed MM, Rabiee A, El Refaye GE, Elsisi HF. Aerobic exercise with mediterranean-DASH intervention for neurodegenerative
delay diet promotes brain cells’ longevity despite sex hormone deficiency in postmenopausal women: a randomized controlled trial.
Oxid Med Cell Longev 2022;2022:4146742. DOI PubMed PMC
133. Liu X, Morris MC, Dhana K, et al. Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: rationale, design
and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline. Contemp Clin Trials
2021;102:106270. DOI PubMed PMC
134. Office for Health Improvement & Disparities. A consensus on healthy ageing. Available from: https://www.gov.uk/government/
publications/healthy-ageing-consensus-statement/a-consensus-on-healthy-ageing. [Last accessed on 15 May 2024].
135. Legrand R, Nuemi G, Poulain M, Manckoundia P. Description of lifestyle, including social life, diet and physical activity, of people ≥
90 years living in Ikaria, a longevity blue zone. Int J Environ Res Public Health 2021;18:6602. DOI PubMed PMC
136. Fastame MC. Well-being, food habits, and lifestyle for longevity. Preliminary evidence from the sardinian centenarians and long-
lived people of the Blue Zone. Psychol Health Med 2022;27:728-33. DOI PubMed
137. Zhang H, Shi N, Diao Z, Chen Y, Zhang Y. Therapeutic potential of TNFα inhibitors in chronic inflammatory disorders: past and
future. Genes Dis 2021;8:38-47. DOI PubMed PMC
138. Sciorati C, Gamberale R, Monno A, et al. Pharmacological blockade of TNFα prevents sarcopenia and prolongs survival in aging
mice. Aging 2020;12:23497-508. DOI PubMed PMC
139. Amor C, Fernández-Maestre I, Chowdhury S, et al. Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-
related metabolic dysfunction. Nat Aging 2024;4:336-49. DOI PubMed PMC
140. Avcı A, Avcı D, Ulaş Y, Ertaş R. Can biologic agents improve treatment success in obese patients with psoriasis vulgaris: a
retrospective review of 320 patients with psoriasis vulgaris. Dermatol Pract Concept 2024;14:e2024058. DOI PubMed PMC
141. Anghel F, Nitusca D, Cristodor P. Body mass index influence for the personalization of the monoclonal antibodies therapy for
psoriasis. Life 2021;11:1316. DOI PubMed PMC
142. Patsalos O, Dalton B, Leppanen J, Ibrahim MAA, Himmerich H. Impact of TNF-α inhibitors on body weight and BMI: a systematic
review and meta-analysis. Front Pharmacol 2020;11:481. DOI PubMed PMC
143. Barros G, Duran P, Vera I, Bermúdez V. Exploring the links between obesity and psoriasis: a comprehensive review. Int J Mol Sci
2022;23:7499. DOI PubMed PMC
144. Grunvald E, Shah R, Hernaez R, et al; AGA Clinical Guidelines Committee. AGA clinical practice guideline on pharmacological
interventions for adults with obesity. Gastroenterology 2022;163:1198-225. DOI
145. Chakhtoura M, Haber R, Ghezzawi M, Rhayem C, Tcheroyan R, Mantzoros CS. Pharmacotherapy of obesity: an update on the
available medications and drugs under investigation. EClinicalMedicine 2023;58:101882. DOI PubMed PMC
146. Giruzzi N. Plenity (oral superabsorbent hydrogel). Clin Diabetes 2020;38:313-4. DOI PubMed PMC
147. Suran M. As ozempic’s popularity soars, here’s what to know about semaglutide and weight loss. JAMA 2023;329:1627-9. DOI
PubMed
148. Han SH, Safeek R, Ockerman K, et al. Public interest in the off-label use of glucagon-like peptide 1 agonists (ozempic) for cosmetic
weight loss: a google trends analysis. Aesthet Surg J 2023;44:60-7. DOI
149. Zhang Y, Li Q, Niu Y, et al. Research progress on aging mechanism and drugs and the role of stem cells in anti-aging process. Exp
Gerontol 2023;179:112248. DOI